Abrysvo
Respiratory Syncytial Virus Vaccine · KIT · Pfizer Laboratories Div Pfizer Inc
Abrysvo is a vaccine that protects against respiratory syncytial virus (RSV), a common virus that can cause serious respiratory illness, particularly in older adults. It is available over the counter and is administered as directed by a healthcare provider or pharmacist.
Key Facts
- Brand Name
- Abrysvo
- Generic Name
- Respiratory Syncytial Virus Vaccine
- NDC Code (Product)
0069-0344- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125769
- Marketing Start
- 07/12/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Abrysvo used for?
Abrysvo is a vaccine that protects against respiratory syncytial virus (RSV), a common virus that can cause serious respiratory illness, particularly in older adults. It is available over the counter and is administered as directed by a healthcare provider or pharmacist.
Is Abrysvo a controlled substance?
Abrysvo is not classified as a controlled substance by the DEA.
What is the generic name for Abrysvo?
The generic name for Abrysvo is Respiratory Syncytial Virus Vaccine. There are 4 other brand versions of Respiratory Syncytial Virus Vaccine.
What is the NDC code for Abrysvo ?
The NDC (National Drug Code) for Abrysvo is 0069-0344, listed by Pfizer Laboratories Div Pfizer Inc.